These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21103684)

  • 1. KDIGO CKD-MBD Discussion forum: the Brazilian perspective.
    Moysés RM; Cancela AL; Gueiros JE; Barreto FC; Neves CL; Canziani ME; Oliveira RB; Jorgetti V; Carvalho AB
    J Bras Nefrol; 2010; 32(3):229-36. PubMed ID: 21103684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The new Kidney Disease: Improving Global Outcomes (KDIGO) guideline for the mineral and bone disorder associated with chronic kidney disease (MBD-CKD)].
    Drüeke TB
    Nephrol Ther; 2010 Jun; 6(3):149-50. PubMed ID: 20188646
    [No Abstract]   [Full Text] [Related]  

  • 3. Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guidelines: a European Renal Best Practice (ERBP) commentary statement.
    Goldsmith DJ; Covic A; Fouque D; Locatelli F; Olgaard K; Rodriguez M; Spasovski G; Urena P; Zoccali C; London GM; Vanholder R
    Nephrol Dial Transplant; 2010 Dec; 25(12):3823-31. PubMed ID: 20829401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The French clinician's guide to the Kidney disease: Improving global outcomes (KDIGO) for chronic kidney disease-mineral and bone disorders (CKD-MBD)].
    Jean G; Chazot C
    Nephrol Ther; 2010 Jun; 6(3):151-7. PubMed ID: 20399169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canadian Society of Nephrology commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD).
    Manns BJ; Hodsman A; Zimmerman DL; Mendelssohn DC; Soroka SD; Chan C; Jindal K; Klarenbach S
    Am J Kidney Dis; 2010 May; 55(5):800-12. PubMed ID: 20438984
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention and control of phosphate retention/hyperphosphatemia in CKD-MBD: what is normal, when to start, and how to treat?
    Martin KJ; González EA
    Clin J Am Soc Nephrol; 2011 Feb; 6(2):440-6. PubMed ID: 21292848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). KDIGO CKD-MBD Clinical Practice Guideline].
    Tsukamoto Y
    Clin Calcium; 2010 Jul; 20(7):1021-7. PubMed ID: 20585180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [K/DOQI clinical practice guidelines for bone metabolism and disease in CKD].
    Sakaguchi T; Akizawa T
    Clin Calcium; 2004 Sep; 14(9):9-14. PubMed ID: 15577103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic kidney disease (CKD) and bone. Targets of serum calcium, phosphate, and parathyroid hormone levels and their controls in maintenance dialysis patients].
    Akiba T
    Clin Calcium; 2009 Apr; 19(4):537-44. PubMed ID: 19329833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone metabolism and disease--K/DOQI impact on nurses and dietitians.
    Knapp S
    Nephrol Nurs J; 2004; 31(3):333-5. PubMed ID: 15303430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The new kidney disease: improving global outcomes (KDIGO) guidelines - expert clinical focus on bone and vascular calcification.
    London G; Coyne D; Hruska K; Malluche HH; Martin KJ
    Clin Nephrol; 2010 Dec; 74(6):423-32. PubMed ID: 21084045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KDOQI US commentary on the KDIGO clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C in CKD.
    Gordon CE; Balk EM; Becker BN; Crooks PA; Jaber BL; Johnson CA; Michael MA; Pereira BJ; Uhlig K; Levin A
    Am J Kidney Dis; 2008 Nov; 52(5):811-25. PubMed ID: 18971009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [KDIGO on CKD-MBD: a new classification for an old problem?].
    Cozzolino M
    G Ital Nefrol; 2009; 26(6):645. PubMed ID: 19918741
    [No Abstract]   [Full Text] [Related]  

  • 14. [KDIGO guidelines for the diagnosis and treatment of chronic kidney disease mineral and bone disorder: what's new?].
    Limardo M; Pontoriero G; Locatelli F
    G Ital Nefrol; 2010; 27(3):211-4. PubMed ID: 20540007
    [No Abstract]   [Full Text] [Related]  

  • 15. Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) guidelines on kidney transplantation: a European Renal Best Practice (ERBP) position statement.
    Heemann U; Abramowicz D; Spasovski G; Vanholder R;
    Nephrol Dial Transplant; 2011 Jul; 26(7):2099-106. PubMed ID: 21555392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Unawareness of the K/DOQI guidelines for bone and mineral metabolism in predialysis chronic kidney disease: results of the OSERCE Spanish multicenter-study survey].
    Bover J; Górriz JL; Martín de Francisco AL; Caravaca F; Barril G; Molinero LM;
    Nefrologia; 2008; 28(6):637-43. PubMed ID: 19016638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The calcium-phosphorus in guidelines for CKD-MBD.
    Yokoyama K
    Kidney Int; 2008 Jul; 74(2):245; author reply 246-7. PubMed ID: 18591947
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chronic kidney disease (CKD) and bone. From renal osteodystrophy to CKD-MBD: new disease entity].
    Tsukamoto Y
    Clin Calcium; 2009 Apr; 19(4):479-84. PubMed ID: 19329825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathogenesis and treatment of vascular calcification in CKD].
    Brancaccio D; Gallieni M; Pasho S; Fallabrino G; Olivi L; Volpi E; Ciceri P; Missaglia E; Ronga C; Brambilla C; Butti A; Rocca-Rey L; Chiarelli G; Cozzolino M
    G Ital Nefrol; 2009; 26 Suppl 45():S20-7. PubMed ID: 19382090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Management of mineral and bone disease caused by chronic renal disease: what recommendations have contributed].
    Houillier P;
    Nephrol Ther; 2008 Sep; 4 Spec No 1():2-8, 15-9. PubMed ID: 19031626
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.